Phase Ib/II trial of lenvatinib plus pembrolizumab in urothelial cancer.

被引：3
|
作者：
Vogelzang, Nicholas J.
Encarnacion, Carlos A.
Cohn, Allen Lee
DiSimone, Christopher
Rasco, Drew W.
Richards, Donald A.
Taylor, Matthew H.
Dutcus, Corina E.
Stepan, Daniel E.
Shumaker, Robert Charles
Guo, Matthew
Schmidt, Emmett V.
Mier, James Walter
机构：
[1] Comprehens Canc Ctr Nevada, Las Vegas, NV USA
[2] Texas Oncol, Waco, TX USA
[3] US Oncol, Rocky Mt Canc Ctr, Denver, CO USA
[4] Arizona Onc Assoc, Tucson, AZ USA
[5] South Texas Accelerated Res Therapeut, San Antonio, TX USA
[6] US Oncol Res, Tyler, TX USA
[7] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[8] Eisai Inc, Woodcliff Lake, NJ USA
[9] Merck & Co Inc, Kenilworth, NJ USA
[10] Dana Farber Harvard Canc Ctr, Beth Israel Deaconess Med Ctr, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 08期
关键词：
D O I：
10.1200/JCO.2019.37.8_suppl.11
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A phase Ib/II trial of lenvatinib plus pembrolizumab in non-small cell lung cancer.
    Brose, Marcia S.
    Vogelzang, Nicholas J.
    DiSimone, Christopher
    Jain, Sharad K.
    Richards, Donald A.
    Encarnacion, Carlos A.
    Rasco, Drew W.
    Shumaker, Robert Charles
    Dutcus, Corina E.
    Stepan, Daniel E.
    Guo, Matthew
    Schmidt, Emmett V.
    Taylor, Matthew H.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
  • [2] A Phase IB/II Trial of Lenvatinib Plus Pembrolizumab in Patients With Endometrial Carcinoma
    Makker, Vicky
    Rasco, Drew
    Dutcus, Corina
    Stepan, Daniel
    Li, Di
    Schmidt, Emmett
    Shumaker, Robert
    Young, Louise
    Taylor, Matthew
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 152 - 153
  • [3] Phase Ib/II trial of lenvatinib plus pembrolizumab in advanced melanoma.
    Taylor, Matthew H.
    Vogelzang, Nicholas J.
    Cohn, Allen Lee
    Stepan, Daniel E.
    Shumaker, Robert Charles
    Dutcus, Corina E.
    Guo, Matthew
    Schmidt, Emmett V.
    Rasco, Drew W.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
  • [4] A Phase IB/II Trial of Lenvatinib plus Pembrolizumab in Patients With Renal Cell Carcinoma
    Lee, Chung-Han
    Makker, Vicky
    Rasco, Drew
    Taylor, Matthew
    Dutcus, Corina
    Shumaker, Robert
    Schmidt, Emmett
    Stepan, Daniel E.
    Li, Di
    Young, Louise
    Motzer, Robert
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 153 - 153
  • [5] A phase Ib/II trial of lenvatinib (LEN) plus pembrolizumab (Pembro) in patients (Pts) with endometrial carcinoma.
    Makker, Vicky
    Rasco, Drew W.
    Dutcus, Corina E.
    Stepan, Daniel E.
    Li, Di
    Schmidt, Emmett V.
    Shumaker, Robert Charles
    Taylor, Matthew H.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [6] Phase II trial of gemcitabine plus cisplatin plus ipilimumab in patients with metastatic urothelial cancer.
    Galsky, Matt D.
    Hahn, Noah M.
    Albany, Costantine
    Fleming, Mark T.
    Starodub, Alexander
    Twardowski, Przemyslaw
    Pal, Sumanta K.
    Hauke, Ralph J.
    Sonpavde, Guru
    Oh, William K.
    Bhardwaj, Nina
    Gnjatic, Sacha
    Kim-Schulze, Seunghee
    Liu, Ziyue
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [7] Phase IB/II Trial of Lenvatinib Plus Pembrolizumab in Patients With Advanced Renal Cell Carcinoma, Endometrial Cancer, and Other Selected Advanced Solid Tumors
    Taylor, Matthew H.
    Lee, Chung-Han
    Makker, Vicky
    Rasco, Drew
    Dutcus, Corina E.
    Wu, Jane
    Stepan, Daniel E.
    Shumaker, Robert C.
    Motzer, Robert J.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (11) : 1154 - +
  • [8] Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma
    Finn, Richard S.
    Ikeda, Masafumi
    Zhu, Andrew X.
    Sung, Max W.
    Baron, Ari D.
    Kudo, Masatoshi
    Okusaka, Takuji
    Kobayashi, Masahiro
    Kumada, Hiromitsu
    Kaneko, Shuichi
    Pracht, Marc
    Mamontov, Konstantin
    Meyer, Tim
    Kubota, Tomoki
    Dutcus, Corina E.
    Saito, Kenichi
    Siegel, Abby B.
    Dubrovsky, Leonid
    Mody, Kalgi
    Llovet, Josep M.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (26) : 2960 - +
  • [9] PHASE II TRIAL OF PEMBROLIZUMAB AND LENVATINIB FOR LEPTOMENINGEAL METASTASES
    Wang, Nancy
    Gerstner, Elizabeth
    Cahill, Daniel
    Oh, Kevin
    Cahill, Jennifer
    Brastianos, Priscilla
    NEURO-ONCOLOGY, 2021, 23 : 48 - 49
  • [10] A phase Ib trial of lenvatinib (LEN) plus pembrolizumab (PEMBRO) in unresectable hepatocellular carcinoma (uHCC): Updated results
    Llovet, J.
    Shepard, K. V.
    Finn, R. S.
    Ikeda, M.
    Sung, M.
    Baron, A. D.
    Kudo, M.
    Okusaka, T.
    Kobayashi, M.
    Kumada, H.
    Kaneko, S.
    Pracht, M.
    Mamontov, K.
    Meyer, T.
    Mody, K.
    Kubota, T.
    Saito, K.
    Siegel, A. B.
    Dubrovsky, L.
    Zhu, A. X.
    ANNALS OF ONCOLOGY, 2019, 30
12345